{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:26:31Z","timestamp":1780806391464,"version":"3.54.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":2515,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13311-016-0446-2","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T09:24:42Z","timestamp":1464081882000},"page":"880-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury"],"prefix":"10.1016","volume":"13","author":[{"given":"Giovanna","family":"Casili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-016-0446-2_bib1","first-page":"617","article-title":"Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago","volume":"30","author":"Whiteneck","year":"1992","journal-title":"Paraplegia"},{"key":"10.1007\/s13311-016-0446-2_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(94)01410-J","article-title":"Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat","volume":"672","author":"Bartholdi","year":"1995","journal-title":"Brain Res"},{"key":"10.1007\/s13311-016-0446-2_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.phrs.2009.01.018","article-title":"PPAR-alpha modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma","volume":"59","author":"Genovese","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-016-0446-2_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.wco.0000044768.39452.5b","article-title":"Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention?","volume":"15","author":"Dumont","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0167-5699(92)90027-5","article-title":"Cervical lymphatics, the blood\u2013brain barrier and the immunoreactivity of the brain: a new view","volume":"13","author":"Cserr","year":"1992","journal-title":"Immunol Today"},{"key":"10.1007\/s13311-016-0446-2_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1227\/01.NEU.0000068865.34216.3A","article-title":"Immunology and immunotherapy in neurosurgical disease","volume":"53","author":"Prins","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-016-0446-2_bib7","first-page":"87","article-title":"Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system","volume":"513","author":"Stoll","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1007\/s13311-016-0446-2_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cnr.2006.09.007","article-title":"Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes","volume":"6","author":"Trivedi","year":"2006","journal-title":"Clin Neurosci Res"},{"key":"10.1007\/s13311-016-0446-2_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00586-011-2060-7","article-title":"Autoreactivity against myelin basic protein in patients with chronic paraplegia","volume":"21","author":"Zajarias-Fainsod","year":"2012","journal-title":"Eur Spine J"},{"key":"10.1007\/s13311-016-0446-2_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.expneurol.2014.03.003","article-title":"Lymphocytes and autoimmunity after spinal cord injury","volume":"258","author":"Jones","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.smim.2014.09.014","article-title":"Spinal cord injury impacts B cell production, homeostasis, and activation","volume":"26","author":"Oropallo","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2012.07.016","article-title":"Improved regeneration after spinal cord injury in mice lacking functional T- and B-lymphocytes","volume":"237","author":"Wu","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib13","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1172\/JCI39780","article-title":"B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice","volume":"119","author":"Ankeny","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-016-0446-2_bib14","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1523\/JNEUROSCI.4703-03.2004","article-title":"Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue","volume":"24","author":"Nitsch","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-016-0446-2_bib15","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1523\/JNEUROSCI.0305-05.2005","article-title":"Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury","volume":"25","author":"Jones","year":"2005","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-016-0446-2_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.it.2010.06.006","article-title":"B cells and autoantibodies: complex roles in CNS injury","volume":"31","author":"Ankeny","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2008.08.008","article-title":"IDO: a double-edged sword for T(H)1\/T(H)2 regulation","volume":"121","author":"Xu","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1007\/s13311-016-0446-2_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0896-6273(00)81118-6","article-title":"A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord","volume":"24","author":"Huang","year":"1999","journal-title":"Neuron"},{"key":"10.1007\/s13311-016-0446-2_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncpneuro0901","article-title":"B cells as therapeutic targets in autoimmune neurological disorders","volume":"4","author":"Dalakas","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","article-title":"Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues","volume":"3","author":"Gold","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1742-2094-8-146","article-title":"Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders","volume":"8","author":"Lehmann-Horn","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-016-0446-2_bib22","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.4049\/jimmunol.179.5.3351","article-title":"Depletion of B cells in murine lupus: efficacy and resistance","volume":"179","author":"Ahuja","year":"2007","journal-title":"J Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib23","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1182\/blood-2009-06-225979","article-title":"Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity","volume":"115","author":"Mossner","year":"2010","journal-title":"Blood"},{"key":"10.1007\/s13311-016-0446-2_bib24","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1074\/jbc.M510171200","article-title":"The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms","volume":"281","author":"Ferrara","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-016-0446-2_bib25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10571-009-9392-4","article-title":"Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: a review","volume":"29","author":"Gal","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"10.1007\/s13311-016-0446-2_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/acn3.94","article-title":"Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain","volume":"1","author":"Anthony","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bcp.2012.02.001","article-title":"The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice","volume":"83","author":"Impellizzeri","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-016-0446-2_bib28","article-title":"The association of palmitoylethanolamide with luteolin decreases autophagy in spinal cord injury","author":"Siracusa","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-016-0446-2_bib29","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2353\/ajpath.2010.100158","article-title":"The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury","volume":"177","author":"Qiao","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-016-0446-2_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/neu.2006.23.635","article-title":"Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains","volume":"23","author":"Basso","year":"2006","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-016-0446-2_bib31","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.18-09-03251.1998","article-title":"Traumatic spinal cord injury induces nuclear factor-kappaB activation","volume":"18","author":"Bethea","year":"1998","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-016-0446-2_bib32","first-page":"1126","article-title":"Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner","volume":"16","author":"Shea","year":"1994","journal-title":"Biotechniques"},{"key":"10.1007\/s13311-016-0446-2_bib33","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1097\/BRS.0b013e3182276d88","article-title":"GW0742, a high-affinity PPAR-delta agonist, mediates protection in an organotypic model of spinal cord damage","volume":"37","author":"Esposito","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1007\/s13311-016-0446-2_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-0102(00)00188-7","article-title":"Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT","volume":"38","author":"Abe","year":"2000","journal-title":"Neurosci Res"},{"key":"10.1007\/s13311-016-0446-2_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-10-91","article-title":"A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury","volume":"10","author":"Paterniti","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-016-0446-2_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2004.10.006","article-title":"Inflammation and apoptosis: linked therapeutic targets in spinal cord injury","volume":"10","author":"Beattie","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1007\/s13311-016-0446-2_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/NMM:7:3:217","article-title":"Failed central nervous system regeneration: a downside of immune privilege?","volume":"7","author":"Bechmann","year":"2005","journal-title":"Neuromolecular Med"},{"key":"10.1007\/s13311-016-0446-2_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/NEN.0b013e3182622691","article-title":"B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model","volume":"71","author":"Jagessar","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib39","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.neuroscience.2008.07.001","article-title":"Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury","volume":"158","author":"Ankeny","year":"2009","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-016-0446-2_bib40","doi-asserted-by":"crossref","first-page":"387513","DOI":"10.1155\/2012\/387513","article-title":"Endogenous proliferation after spinal cord injury in animal models","volume":"2012","author":"McDonough","year":"2012","journal-title":"Stem Cells Int"},{"key":"10.1007\/s13311-016-0446-2_bib41","first-page":"98","article-title":"Calibrated forceps model of spinal cord compression injury","volume":"24","author":"McDonough","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1007\/s13311-016-0446-2_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-11-6","article-title":"Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies","volume":"11","author":"Paterniti","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-016-0446-2_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3171\/jns.1998.89.5.0699","article-title":"Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial","volume":"89","author":"Bracken","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-016-0446-2_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3171\/spi.2004.1.3.0311","article-title":"Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats","volume":"1","author":"La Rosa","year":"2004","journal-title":"J Neurosurg Spine"},{"key":"10.1007\/s13311-016-0446-2_bib45","first-page":"1683","article-title":"The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-kappaB\/Snail\/RKIP\/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis","volume":"38","author":"Baritaki","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1007\/s13311-016-0446-2_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0065-2776(08)60742-7","article-title":"NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules","volume":"65","author":"Baeuerle","year":"1997","journal-title":"Adv Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib47","doi-asserted-by":"crossref","first-page":"e87131","DOI":"10.1371\/journal.pone.0087131","article-title":"IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential","volume":"9","author":"Lehmann","year":"2014","journal-title":"PLoS One"},{"key":"10.1007\/s13311-016-0446-2_bib48","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.170.9.4497","article-title":"Determinants of human B cell migration across brain endothelial cells","volume":"170","author":"Alter","year":"2003","journal-title":"J Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2009.06471.x","article-title":"Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma","volume":"112","author":"Paterniti","year":"2010","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-016-0446-2_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10571-015-0218-2","article-title":"Astrocytes and microglia-mediated immune response in maladaptive plasticity is differently modulated by NGF in the ventral horn of the spinal cord following peripheral nerve injury","volume":"36","author":"De Luca","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.1007\/s13311-016-0446-2_bib51","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","article-title":"Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis","volume":"258","author":"Axelsson","year":"2011","journal-title":"J Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-016-0446-2_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","article-title":"GFAP and astrogliosis","volume":"4","author":"Eng","year":"1994","journal-title":"Brain Pathol"},{"key":"10.1007\/s13311-016-0446-2_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jnen\/61.7.623","article-title":"The neuropathological and behavioral consequences of intraspinal microglial\/macrophage activation","volume":"61","author":"Popovich","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-016-0446-2_bib55","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.neuroscience.2008.08.021","article-title":"Immune depression syndrome following human spinal cord injury (SCI): a pilot study","volume":"158","author":"Riegger","year":"2009","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-016-0446-2_bib56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2177\/jsci.33.234","article-title":"Regulatory B cell and autoimmune disease","volume":"33","author":"Matsushita","year":"2010","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1007\/s13311-016-0446-2_bib57","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.4049\/jimmunol.0804328","article-title":"The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity","volume":"182","author":"Scott","year":"2009","journal-title":"J Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib58","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI40839","article-title":"Pathogenic antibodies are active participants in spinal cord injury","volume":"119","author":"Dekaban","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-016-0446-2_bib59","first-page":"19","article-title":"Spotlight on anti-CD20","volume":"15","author":"Waubant","year":"2008","journal-title":"Int MS J"},{"key":"10.1007\/s13311-016-0446-2_bib60","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2014-07-588376","article-title":"Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies","volume":"125","author":"Tipton","year":"2015","journal-title":"Blood"},{"key":"10.1007\/s13311-016-0446-2_bib61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2015.1038342","article-title":"Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma","volume":"24","author":"Merli","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1007\/s13311-016-0446-2_bib62","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2006.04147.x","article-title":"Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis","volume":"99","author":"Ankeny","year":"2006","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-016-0446-2_bib63","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/15384047.2014.1003006","article-title":"Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4 + Foxp3+ regulatory T cells (Tregs) in mice","volume":"16","author":"Li","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1007\/s13311-016-0446-2_bib64","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.4049\/jimmunol.1001519","article-title":"IL-17- and IFN-gamma-secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity","volume":"185","author":"Esposito","year":"2010","journal-title":"J Immunol"},{"key":"10.1007\/s13311-016-0446-2_bib65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.brainresrev.2007.01.013","article-title":"Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation","volume":"54","author":"Conti","year":"2007","journal-title":"Brain Res Rev"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-016-0446-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-016-0446-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-016-0446-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-016-0446-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:46Z","timestamp":1761807886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923015039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1878747923015039"],"URL":"https:\/\/doi.org\/10.1007\/s13311-016-0446-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-016-0446-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}